Remove Pharma Remove Safety Remove Side effects
article thumbnail

As FDA puts CAR-T safety under microscope, researchers dig into adverse events record of BCMA therapies

Fierce Pharma

But these immunotherapies also come with various potentially dangerous side effects. | A new study examined side effect reports of BMCA immunotherapies from the FDA Adverse Event Reporting System, hoping to help inform doctors in their treatment decisions.

article thumbnail

Apellis flags needle problems in hunt for Syfovre side effect source

Fierce Pharma

While nothing is certain yet, Apellis may be homing in on the source of a rare but serious side effect tied to its world-first geographic atrophy drug Syfovre. While nothing is certain yet, Apellis may be homing in on the source of a rare but serious side effect tied to its world-first geographic atrophy drug Syfovre.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

B. Braun, Baxter launch separate recalls over particulate concerns and excess endotoxin levels, respectively

Fierce Pharma

While neither recall has resulted in any safety flags or side effect reports so far, the issues stemming from the faulty products could be severe, the drugmakers have warned.

article thumbnail

Unfair balance

World of DTC Marketing

I just finished an analysis of a pharma clients website using their analytics. While the product safety information page is among the top five pages visited what alarmed me was that time on the page was measured in seconds not minutes for most online visitors. For some reason, the FDA still requires fair balance on website home pages.

article thumbnail

Organon's prolific asthma med Singulair needs new safety labeling, NY attorney general argues

Fierce Pharma

Organon’s inherited asthma med Singulair is back in the spotlight for the wrong reasons after New York Attorney General Letitia James raised fresh concerns about the drug’s neuropsychiatric side ef | Organon’s inherited asthma med Singulair is back in the spotlight for the wrong reasons after New York Attorney General Letitia James raised fresh concerns (..)

article thumbnail

Apellis attempts to clear the air around Syfovre safety as eye drug launch gains steam

Fierce Pharma

For Apellis Pharmaceuticals, the emergence of rare but serious side effects has cast a pall over the launch of the company’s geographic atrophy med Syfovre. While touting the “strong commercial execution” of Syfovre’s launch, Apellis’ CEO Cedric Francois, M.D.,

article thumbnail

Pay Per Click Essentials for Pharma Marketing Executives: A Beginner’s Guide

Pharma Marketing Network

In today’s digital-first world, Pay Per Click (PPC) advertising has become an essential strategy for pharma marketing executives. Why PPC Matters in Pharma Marketing Why invest in PPC? Compliance and Regulatory Considerations Pharma marketing is heavily regulated, and PPC is no exception. PPC does just that. Simple: visibility.